Immune checkpoint inhibitor-related pancreatitis: What is known and what is not

A 47-year-old man presented with a 1 week history of progressive fatigue and decreased appetite. He had stage IV oral squamous cell carcinoma and was treated with sintilimab, a programmed cell death protein 1 inhibitor, 22 months earlier. Laboratory work-up revealed significant elevation of bilirubi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Chunyan, Tang, Wen, Yang, Xu, Li, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238808/
https://www.ncbi.nlm.nih.gov/pubmed/37273919
http://dx.doi.org/10.1515/med-2023-0713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238808/
https://www.ncbi.nlm.nih.gov/pubmed/37273919
http://dx.doi.org/10.1515/med-2023-0713

Ejemplares similares